A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With Diethylstilbestrol
Clinical trial NCT04268628 · COMPLETED
Trial details
- NCT number
- NCT04268628
- Sponsor
- Janssen-Cilag Farmaceutica Ltda.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-19
- Primary completion
- 2020-11-16
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.